Avantor, Inc. provides products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries worldwide.
Avantor stock last closed at $24.99, up 0.04% from the previous day, and has increased 23.22% in one year. It has overperformed other stocks in the Specialty Chemicals industry by 0.07 percentage points. Avantor stock is currently +50.27% from its 52-week low of $16.63, and -4.47% from its 52-week high of $26.16.
At the moment, there are 679.27M AVTR shares outstanding. The market value of AVTR is $16.97B. In the past 24 hours, 3.32M AVTR shares were traded.
You need a brokerage account to access the NYSE market and buy AVTR shares.
Based on our analysis, eToro is the best brokerage. Here's why:
Get $10 towards your share purchase by creating an account with eToro now.
Open eToro AccountNow that you've chosen the right brokerage, you need to fill out some personal information so you can invest in AVTR today.
Now that you've finished signing up on apps for stock market, you need to deposit funds:
Check out the video below if you need help transferring money into your new brokerage account.
Once you have identified the best place to buy Avantor stock, it's important to evaluate their stock before you invest, so you can comprehend the risk and opportunity.
WallStreetZen was created to help part-time investors perform better fundamental analysis in less time.
You can view all of the due diligence checks on AVTR's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge AVTR's intrinsic value.
Using relative valuations ratios:
You can do additional valuation analysis on AVTR's stock here.
Out of 10 Wall Street analysts who give recommendations on AVTR, the consensus analyst rating on Avantor is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Patrick B Donnelly, a top 13% analyst from Citigroup maintains AVTR with a strong buy rating and raises their AVTR price target from $24.00 to $30.00, on Feb 15, 2024.
Citigroup's Patrick B Donnelly raised their price target on Avantor (NYSE: AVTR) by 25% from $24 to $30 on 2024/02/15. The analyst maintained their Strong Buy rating on the stock.
"Management took a more prudent approach to its guidance framework, which was a positive," Donnelly said after reviewing Avantor's Q4 and FY 2023 earnings, reported on 2024/02/14.
In addition, management outlined the reasons it is confident the company can return to a greater than 20% adjusted EBITDA margin by the end of FY 2025, the analyst said, adding that "there is potential upside to that timeline."
Avantor reported:
For Q4 2023:
For FY 2023:
President & CEO Michael Stubblefield commented: " We had a strong finish to the year.
"Looking ahead to 202, while we are seeing encouraging signs from our customers and end markets, we have not yet seen an inflection point.
"We are continuing to take actions that position Avantor for long-term growth, including advancing our new operating model which unlocks significant operating efficiencies, sharpens our focus on accelerating innovation, and builds on the strength of our platform."
Conor McNamara, a bottom 5% analyst from RBC Capital maintains AVTR with a buy rating and raises their AVTR price target from $28.00 to $29.00, on Feb 15, 2024.
Jeffrey Zekauskas, a top 7% analyst from JP Morgan maintains AVTR with a strong buy rating and raises their AVTR price target from $26.00 to $29.00, on Feb 15, 2024.
Andrew Cooper, a bottom 2% analyst from Raymond James maintains AVTR with a buy rating and raises their AVTR price target from $22.50 to $26.00, on Jan 26, 2024.
Matthew Sykes, a top 16% analyst from Goldman Sachs maintains AVTR with a strong buy rating and raises their AVTR price target from $23.00 to $26.00, on Dec 7, 2023.
You can dive deeper into what analysts are forecasting on the Avantor stock forecast page.
Last year, AVTR earnings were $260.00M. In the past 3 year, AVTR's earnings have gone up by 70.12% per year. This was faster than the Specialty Chemicals industry average of 3.56%.
Last year, AVTR revenue was $6.87B. During the last five year, AVTR's revenue has grown by 2.99% per year. This was slower than the Specialty Chemicals industry average of 7.03%.
Find out more about AVTR's earnings and revenue performance here.
Over the last 12 months, insiders at AVTR have sold more shares than they have bought.
Randy Lee Stone, EVP Laboratory Solutions of AVTR, was the latest AVTR insider to sell. They sold $166,345.20 worth of AVTR stock on Apr 16, 2024.
Research more about who owns AVTR stock here.
No, Avantor doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other investors have to say.
You have two primary order types:
Press the Open Trade button and your broker will place the order.
If you want more help with buying stocks on eToro, watch the how to video below:
Now that you own some AVTR stock, you'll want to keep up with your investment.
Create a watchlist to keep track of your AVTR stock.
To summarize, here are the 6 steps for buying Avantor stock:
If you are looking for a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you want to keep track of your investment in Avantor, click below.